ENTRY       D12178                      Drug
NAME        Sotigalimab (USAN)
FORMULA     C6412H9970N1708O1993S46
EXACT_MASS  144257.8461
MOL_WEIGHT  144347.008
SEQUENCE    (Heavy chain)
            XVQLVESGGG VVQPGRSLRL SCAASGFSFS STYVCWVRQA PGKGLEWIAC IYTGDGTNYS
            ASWAKGRFTI SKDSSKNTVY LQMNSLRAED TAVYFCARPD ITYGFAINFW GPGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVE HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE
            LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT IKCQASQSIS SRLAWYQQKP GKPPKLLIYR ASTLASGVPS
            RFSGSGSGTD FTLTISSLQP EDVATYYCQC TGYGISWPIG GGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H35-H50, H147-H203, H223-L215, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'35-H'50, H'147-H'203, H'223-L'215, H'264-H'324, H'370-H'428, L23-L88, L135-L195, L'23-L'88, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancer
TARGET      TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  PATHWAY   hsa04060(958)  Cytokine-cytokine receptor interaction
            hsa04514(958)  Cell adhesion molecules
            hsa04620(958)  Toll-like receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF5 (CD40)
                 D12178  Sotigalimab (USAN)
DBLINKS     CAS: 2305607-45-6
///
